RESUMO
Purpose To detect the expression of N-Myc and p53 in the tissues of prostate cancer (PCa) patients and to explore the relationship between them and their significance.Methods A total of 63 patients with PCa and 50 patients with benign prostatic hyperplasia (BPH) who underwent prostate surgery at the First Affiliated Hospital of Anhui Medical University were recruited in 2015-2016. The expression of N-Myc and p53 in pathological tissues were detected by immunohistochemistry of MaxVision method. Results The expression of N-Myc and p53 in PCa tissues was increased (P < 0.05). The expression of N-Myc and p53 in PCa tissues was correlated with bone metastases and TNM stage (P < 0.05), but not related to patient age, preoperative PSA level and other factors (P> 0.05). In addition, the expression of p53 was also correlated with Gleason score.Conclusion The high expression of N-Myc and p53 in PCa may involved in the malignant progression and metastasis of prostate cancer, and it is expected to become a new target for detecting PCa metastasis.
RESUMO
Purpose To detect the expression of miR-421 in serum and tissues of prostate cancer ( PCa) and its clinical value inPCa. Methods 62 cases of PCa and 46 cases of benign prostatic hyperplasia (BPH) were enrolled in the Department of Urology, the First Affiliated Hospital of Anhui Medical Universi-ty from December 2015 to December 2016. Another 42 cases of paraffin-embedded sections of PCa and 37 cases of BPH were al-so used in this study. The expression of miR-421 in serum was detected by real-time PCR (qRT-PCR). The expression of miR-421 in tissues was detected by in situ hybridization. Results The expression of miR-421 in serum of patients with PCa and BPH was ( 2. 52 ± 1. 70 ) and ( 0. 82 ± 0. 65 ), respectively. Compared with the expression of BPH, the expression of miR- 421 in serum of PCa was increased (P＜0. 05). The expression of miR-421 in serum and tissues of patients with PCa was corre-lated with Gleason score, TNM clinical stage, and bone metasta-ses (P＜0. 05). It was not related to the patient's age, preop-erative PSA level and other factors ( P＞0. 05). Conclusion miR-421 is more abundant in PCa patients than that in patients with benign prostatic hyperplasia, and is expected to become a diagnostic marker for PCa.